Women taking epilepsy medication who may be pregnant urged to discuss treatment options
News
Tocilizumab and sarilumab cut risk of death in severe COVID-19 patients
Anti-inflammatory drugs also accelerated patients’ recovery times
NHS Digital pilot will collect private hospital data
Pilot will be led by NHS Digital and the Private Healthcare Information Network
NICE no for BMS’ Opdivo for head and neck cancer
Opdivo is currently available on the Cancer Drugs Fund
Back-to-back winner reveals the exceptional challenges and rewards in the International Clinical Researcher of the Year competition
The prestigious PharmaTimes INTCR competition has amassed a strong following since its introduction over two decades ago, with many of the fantastic finalists eager to show their support.
New COVID-19 drug screening hub established in Scotland
Life Arc funds hub based at the University of Glasgow
Skyrizi bags positive psoriatic arthritis results
KEEPsAKE-1 and KEEPsAKE-2 studies demonstrated significant improvements in Skyrizi-treated patients
The Health Research Authority launches fast-track service for non-COVID-19 research
Service will accelerate the ethics review stage of clinical trials approval
EU approves Moderna’s COVID-19 vaccine
Vaccine is also currently being reviewed in the UK
EU authorises intramuscular administration of Biogen’s Plegridy for MS
New administration option for relapsing-remitting MS patients
Allergy Therapeutics launches biomarker study of peanut allergy vaccine candidate
Study will take place at Imperial College London
US priority review for Forxiga in chronic kidney disease
AZ is aiming for approval in adults with and without type 2 diabetes
University of Birmingham researchers develop rapid COVID-19 RNA test
Test can give accurate results in under five minutes, according to researchers
Angelini Pharma acquires CNS specialist Arvelle Therapeutics
Key focus of the deal is focal-onset seizure treatment cenobamate
EMA launches review of BMS’ Opdivo for oesophageal cancer
Company is aiming for approval in the adjuvant setting
